Top compounds associated with response to RGCC


Feature Type Standardized
Nominal ANOVA
mRNA Dasatinib GDSC1000 pan-cancer AAC 0.17 0.001
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.097 0.002
mRNA piperlongumine GDSC1000 pan-cancer AAC -0.1 0.002
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA CH5424802 GDSC1000 pan-cancer AAC -0.1 0.003
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA FK866 GDSC1000 pan-cancer AAC -0.089 0.005
mRNA XMD13-2 GDSC1000 pan-cancer AAC -0.087 0.006
mRNA lapatinib GDSC1000 pan-cancer AAC 0.13 0.008
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.008
Download CSV